Beutel, Goodman & Co’s CRH Medical Corporation CRHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,958,612
| Closed | -$15.6M | – | 66 |
|
|
2021
Q1 | $15.6M | Sell |
3,958,612
-1,390,158
| -26% | -$4.5M | 0.1% | 57 |
|
|
2020
Q4 | $12.5M | Buy |
5,348,770
+1,457,508
| +37% | +$3.57M | 0.08% | 53 |
|
|
2020
Q3 | $8.44M | Sell |
3,891,262
-89,380
| -2% | -$208K | 0.07% | 53 |
|
|
2020
Q2 | $8.24M | Sell |
3,980,642
-275,720
| -6% | -$557K | 0.07% | 52 |
|
|
2020
Q1 | $5.7M | Sell |
4,256,362
-112,988
| -3% | -$369K | 0.05% | 52 |
|
|
2019
Q4 | $15.2M | Sell |
4,369,350
-164,500
| -4% | -$519K | 0.09% | 54 |
|
|
2019
Q3 | $13.9M | Sell |
4,533,850
-54,100
| -1% | -$161K | 0.1% | 53 |
|
|
2019
Q2 | $13.8M | Sell |
4,587,950
-137,010
| -3% | -$392K | 0.1% | 52 |
|
|
2019
Q1 | $12.5M | Sell |
4,724,960
-402,140
| -8% | -$1.24M | 0.09% | 52 |
|
|
2018
Q4 | $15.7M | Buy |
5,127,100
+171,970
| +3% | +$567K | 0.13% | 51 |
|
|
2018
Q3 | $19.7M | Sell |
4,955,130
-93,370
| -2% | -$344K | 0.14% | 52 |
|
|
2018
Q2 | $15.8M | Sell |
5,048,500
-137,900
| -3% | -$440K | 0.12% | 50 |
|
|
2018
Q1 | $13.1M | Sell |
5,186,400
-58,300
| -1% | -$164K | 0.1% | 49 |
|
|
2017
Q4 | $13.9M | Buy |
+5,244,700
| New | +$11.7M | 0.09% | 53 |
|
Beutel, Goodman & Co's CRHM Position: Q2 2021 in Review
Beutel, Goodman & Co sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 3,958,612 shares — an estimated $15.6M sold.
Beutel, Goodman & Co first reported a position in CRHM in Q4 2017 and held it in 14 quarters. The position peaked at $19.7M in Q3 2018. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.
- Beutel, Goodman & Co reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Beutel, Goodman & Co sold 3,958,612 CRH Medical Corporation shares in Q2 2021, an estimated $15.6M.
- Beutel, Goodman & Co first reported a position in CRH Medical Corporation in Q4 2017 and held it in 14 quarters.
- Beutel, Goodman & Co's CRH Medical Corporation position peaked at $19.7M in Q3 2018.
- 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.
Based on Beutel, Goodman & Co's 13F filing for Q2 2021, filed 13 Aug 2021.